$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2014 Q3 Form 10-Q Financial Statement

#000114420414051039 Filed on August 18, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $139.00 $303.00 $451.00
YoY Change -44.84% -32.82%
Cost Of Revenue
YoY Change
Gross Profit $139.00 $303.00 $451.00
YoY Change -44.84% -32.82%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $10.00K $20.00K $20.00K
YoY Change 0.0%
% of Gross Profit 7194.24% 6600.66% 4434.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $6.259K $16.32K $15.25K
YoY Change 25.63% 7.06%
Operating Profit -$6.120K -$16.02K -$14.80K
YoY Change 29.39% 8.27%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.327K
YoY Change
Pretax Income -$6.120K -$16.02K -$19.12K
YoY Change 19.27% -16.23%
Income Tax
% Of Pretax Income
Net Earnings -$6.120K -$16.02K -$19.12K
YoY Change 19.27% -16.23%
Net Earnings / Revenue -4402.88% -5286.8% -4239.91%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.972K -$3.945K -$4.444K
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $599.00 $680.00 $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $599.00 $680.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $599.00 $680.00 $0.00
YoY Change -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $10.00K $0.00
YoY Change
Accrued Expenses $0.00 $11.70K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $20.00K $0.00 $30.00K
YoY Change -33.33% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.11K $20.07K $30.00K
YoY Change -12.96% -33.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.11K $20.07K $30.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $26.11K $20.07K $30.00K
YoY Change -12.96% -33.09% 50.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $5.073K $5.073K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.51K -$19.39K -$30.00K
YoY Change
Total Liabilities & Shareholders Equity $599.00 $680.00 $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$6.120K -$16.02K -$19.12K
YoY Change 19.27% -16.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.00K $0.00 -$20.00K
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 0.000 10.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -20.00K 0.000 -20.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 20.00K 0.000 10.00K
Net Change In Cash 0.000 0.000 -10.00K
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$20.00K $0.00 -$20.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
osok Adjustments To Additional Paid In Capital Forgiveness Accounts Payable Related Party
AdjustmentsToAdditionalPaidInCapitalForgivenessAccountsPayableRelatedParty
952 USD
osok Adjustments To Additional Paid In Capital Forgiveness Convertible Debt Related Party
AdjustmentsToAdditionalPaidInCapitalForgivenessConvertibleDebtRelatedParty
6952 USD
osok Adjustments To Additional Paid In Capital Forgiveness Debt Related Party
AdjustmentsToAdditionalPaidInCapitalForgivenessDebtRelatedParty
23242 USD
osok Extinguishment Of Convertible Debt Amount
ExtinguishmentOfConvertibleDebtAmount
6000 USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
952 USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
952 USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
6952 USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
6952 USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
23242 USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
23242 USD
CY2014Q1 osok Related Party Accrued Interest
RelatedPartyAccruedInterest
1242 USD
CY2014Q1 osok Related Party Forgiven Interest Convertible Notes Payable
RelatedPartyForgivenInterestConvertibleNotesPayable
952 USD
CY2014Q1 osok Shares Sold By Former Director
SharesSoldByFormerDirector
3500000 shares
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
952 USD
CY2014Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
8370 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
us-gaap Accretion Of Discount
AccretionOfDiscount
330 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
4000 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
4330 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11702 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45577 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
13500 USD
us-gaap Advertising Expense
AdvertisingExpense
USD
us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q2 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2013Q2 us-gaap Advertising Expense
AdvertisingExpense
USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2013Q4 us-gaap Assets
Assets
525 USD
CY2014Q2 us-gaap Assets
Assets
680 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
525 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
680 USD
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2014Q2 us-gaap Cash
Cash
680 USD
CY2009Q3 us-gaap Cash
Cash
USD
CY2013Q2 us-gaap Cash
Cash
1338 USD
CY2012Q4 us-gaap Cash
Cash
1118 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
155 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
220 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
680 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
5073 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <u>Products and services, geographic areas and major customers</u></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The Company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</p> <!--EndFragment--></div> </div>
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
6000 USD
CY2014Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
us-gaap Cost Of Revenue
CostOfRevenue
USD
us-gaap Cost Of Revenue
CostOfRevenue
USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
USD
us-gaap Cost Of Revenue
CostOfRevenue
2138 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
80941 USD
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
101188 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2014Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.69 pure
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
22000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22430 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16019 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20385 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18637 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16322 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15246 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
102457 USD
us-gaap Gross Profit
GrossProfit
468 USD
us-gaap Gross Profit
GrossProfit
857 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
303 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
451 USD
us-gaap Gross Profit
GrossProfit
7463 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20247 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19122 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-101188 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11702 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
650 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13566 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20072 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
74650 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
8370 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
9322 USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1864 USD
CY2014Q2 us-gaap Interest Payable Current
InterestPayableCurrent
USD
CY2013Q4 us-gaap Liabilities
Liabilities
30816 USD
CY2014Q2 us-gaap Liabilities
Liabilities
20072 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
525 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
680 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30816 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
155 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17780 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-73970 USD
us-gaap Net Income Loss
NetIncomeLoss
-20247 USD
us-gaap Net Income Loss
NetIncomeLoss
-22430 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-16019 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-19122 USD
us-gaap Net Income Loss
NetIncomeLoss
-101188 USD
us-gaap Net Income Loss
NetIncomeLoss
-2779 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-6044 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-27604 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-13960 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-30554 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-19917 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17780 USD
CY2014Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4327 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6194 USD
us-gaap Operating Expenses
OperatingExpenses
20385 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16019 USD
us-gaap Operating Expenses
OperatingExpenses
18637 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
16322 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
15246 USD
us-gaap Operating Expenses
OperatingExpenses
102457 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14795 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-94994 USD
CY2013Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
22000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4650 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
13500 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
33150 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
468 USD
us-gaap Sales Revenue Net
SalesRevenueNet
857 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
303 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
451 USD
us-gaap Sales Revenue Net
SalesRevenueNet
9601 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30291 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-19392 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-17237 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-3277 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-4323 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-1221 USD
CY2009Q3 us-gaap Stockholders Equity
StockholdersEquity
USD
us-gaap Stock Issued During Period Shares Issued For Noncash Consideration
StockIssuedDuringPeriodSharesIssuedForNoncashConsideration
1000 shares
CY2010 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
500 USD
CY2011 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
28650 USD
us-gaap Stock Issued During Period Value Issued For Noncash Considerations
StockIssuedDuringPeriodValueIssuedForNoncashConsiderations
3000 USD
us-gaap Use Of Estimates
UseOfEstimates
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <u>Use of Estimates</u></p> <p style="TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <!--EndFragment--></div> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4500000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4500000 shares

Files In Submission

Name View Source Status
0001144204-14-051039-index-headers.html Edgar Link pending
0001144204-14-051039-index.html Edgar Link pending
0001144204-14-051039.txt Edgar Link pending
0001144204-14-051039-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
osok-20140630.xml Edgar Link completed
osok-20140630.xsd Edgar Link pending
osok-20140630_cal.xml Edgar Link unprocessable
osok-20140630_def.xml Edgar Link unprocessable
osok-20140630_lab.xml Edgar Link unprocessable
osok-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v386660_10q.htm Edgar Link pending
v386660_ex31.htm Edgar Link pending
v386660_ex32.htm Edgar Link pending